ninlaro 3mg capsules
takeda uk ltd - ixazomib citrate - capsule - 3mg
ninlaro 2.3mg capsules
takeda uk ltd - ixazomib citrate - capsule - 2.3mg
ninlaro 4mg capsules
takeda uk ltd - ixazomib citrate - capsule - 4mg
ninlaro 2.3 mg
takeda israel ltd - ixazomib as citrate - capsules - ixazomib as citrate 2.3 mg - ixazomib - ninlaro is indicated, in combination with lenalidomide and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.
ninlaro 2.3 mg
takeda israel ltd - ixazomib as citrate - capsules - ixazomib as citrate 2.3 mg - ixazomib - ninlaro is indicated, in combination with lenalidomide and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.
ninlaro 3 mg
takeda israel ltd - ixazomib as citrate - capsules - ixazomib as citrate 3 mg - ixazomib - ninlaro is indicated, in combination with lenalidomide and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.
ninlaro 3 mg
takeda israel ltd - ixazomib as citrate - capsules - ixazomib as citrate 3 mg - ixazomib - ninlaro is indicated, in combination with lenalidomide and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.
ninlaro 4 mg
takeda israel ltd - ixazomib as citrate - capsules - ixazomib as citrate 4 mg - ixazomib - ninlaro is indicated, in combination with lenalidomide and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.
ninlaro 4 mg
takeda israel ltd - ixazomib as citrate - capsules - ixazomib as citrate 4 mg - ixazomib - ninlaro is indicated, in combination with lenalidomide and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.
ninlaro capsule 2.3mg
takeda pharmaceuticals (asia pacific) pte. ltd. - ixazomib citrate 3.3mg eqv ixazomib - capsule - ixazomib citrate 3.3mg eqv ixazomib 2.3mg